Molecular alterations and clinicopathological features in sporadic duodenal adenocarcinoma

Molecular alterations and clinicopathological features in sporadic duodenal adenocarcinoma - Molecular alterations in duodenal adenocarcinoma

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000023622

Enrollment

Registered

2016-08-15

Start date

2016-05-20

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Primary extra-ampullary duodenal adenocarcinoma

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Primary extra-ampullary duodenal adenocarcinoma

Exclusion criteria

Exclusion criteria: 1) Patients with a known familial cancer syndrome including familial adenomatous polyposis 2) Patients who have determined by the physicians to have any reasons of unqualified

Design outcomes

Primary

Measure	Time frame
Molecular analyses in duodenal adenocarcinoma	—

Secondary

Measure	Time frame
Association between clinicopathological features including mucin phenotype and molecular alterations in duodenal adenocarcinoma	—

Countries

Japan

Contacts

Public ContactJiro Watari

Hyogo College of Medicine Division of Gastroenterology, Department of Internal Medicine

watarij@hyo-med.ac.jp0798-45-6662

Outcome results